Evaluation of A-ring fused pyridine d-modified androstane derivatives for antiproliferative and aldo-keto reductase 1C3 inhibitory activityElectronic supplementary information (ESI) available: IR, 1H and 13C NMR and HRMS spectra. CCDC CCDC 1823137-1823139. For ESI and crystallographic data in CIF or other electronic format see DOI: 10.1039/c8md00077h
New A-ring pyridine fused androstanes in 17a-homo-17-oxa ( d -homo lactone), 17α-picolyl or 17( E )-picolinylidene series were synthesized and validated by X-ray crystallography, HRMS, IR and NMR spectroscopy. Novel compounds 3 , 5 , 8 and 12 were prepared by treatment of 4-en-3-one or 4-ene-3,6-dio...
Saved in:
Main Authors | , , , , , , , , |
---|---|
Format | Journal Article |
Language | English |
Published |
20.06.2018
|
Online Access | Get full text |
Cover
Loading…
Summary: | New A-ring pyridine fused androstanes in 17a-homo-17-oxa (
d
-homo lactone), 17α-picolyl or 17(
E
)-picolinylidene series were synthesized and validated by X-ray crystallography, HRMS, IR and NMR spectroscopy. Novel compounds
3
,
5
,
8
and
12
were prepared by treatment of 4-en-3-one or 4-ene-3,6-dione
d
-modified androstane derivatives with propargylamine catalyzed by Cu(
ii
), and evaluated for potential anticancer activity
in vitro
using human cancer cell lines and recombinant targets of steroidal anti-cancer drugs. Pyridine fusion to position 3,4 of the A-ring may dramatically enhance affinity of 17α-picolyl compounds for CYP17 while conferring selective antiproliferative activity against PC-3 cells. Similarly, pyridine fusion to the A-ring of steroidal
d
-homo lactones led to identification of new inhibitors of aldo-keto reductase 1C3, an enzyme targeted in acute myeloid leukemia, breast and prostate cancers. One A-pyridine
d
-lactone steroid
5
also has selective submicromolar antiproliferative activity against HT-29 colon cancer cells. None of the new derivatives have affinity for estrogen or androgen receptors in a yeast screen, suggesting negligible estrogenicity and androgenicity. Combined, our results suggest that A-ring pyridine fusions have potential in modulating the anticancer activity of steroidal compounds.
New A-ring pyridine fused androstanes in
d
-homo lactone, 17α-picolyl or 17(
E
)-picolinylidene series were synthesized and validated. |
---|---|
Bibliography: | 1 For ESI and crystallographic data in CIF or other electronic format see DOI 13 C NMR and HRMS spectra. CCDC CCDC 1823137-1823139 10.1039/c8md00077h H and Electronic supplementary information (ESI) available: IR |
ISSN: | 2040-2503 2040-2511 |
DOI: | 10.1039/c8md00077h |